TR199901450T2 - Helicobacter pylori canli asisi. - Google Patents
Helicobacter pylori canli asisi.Info
- Publication number
- TR199901450T2 TR199901450T2 TR1999/01450T TR9901450T TR199901450T2 TR 199901450 T2 TR199901450 T2 TR 199901450T2 TR 1999/01450 T TR1999/01450 T TR 1999/01450T TR 9901450 T TR9901450 T TR 9901450T TR 199901450 T2 TR199901450 T2 TR 199901450T2
- Authority
- TR
- Turkey
- Prior art keywords
- helicobacter pylori
- canl
- pylori
- vaccines
- infection
- Prior art date
Links
- 241000590002 Helicobacter pylori Species 0.000 title abstract 2
- 229940037467 helicobacter pylori Drugs 0.000 title abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/205—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Campylobacter (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Bu bulus, Helicobacter pylori tarafindan bir enfeksiyona karsi koruyucu bagisiklik temin eden yeni rekombinant canli asilara ve eniyilenmis asilar için H. pylori antigenlerinin taranmasi için bir yönteme iliskindir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP96116337A EP0835928A1 (en) | 1996-10-11 | 1996-10-11 | Helicobacter pylori live vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199901450T2 true TR199901450T2 (tr) | 1999-10-21 |
Family
ID=8223286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR1999/01450T TR199901450T2 (tr) | 1996-10-11 | 1997-09-01 | Helicobacter pylori canli asisi. |
Country Status (15)
Country | Link |
---|---|
EP (2) | EP0835928A1 (tr) |
JP (1) | JP2001510986A (tr) |
KR (1) | KR100510928B1 (tr) |
CN (1) | CN1215167C (tr) |
AT (1) | ATE392429T1 (tr) |
AU (1) | AU734635B2 (tr) |
BR (1) | BR9713254A (tr) |
CA (1) | CA2268033A1 (tr) |
DE (1) | DE69738641D1 (tr) |
IL (1) | IL129366A0 (tr) |
NO (1) | NO991692L (tr) |
NZ (1) | NZ335050A (tr) |
PL (1) | PL332575A1 (tr) |
TR (1) | TR199901450T2 (tr) |
WO (1) | WO1998016552A1 (tr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6248551B1 (en) * | 1997-03-28 | 2001-06-19 | Institut Pasteur | Helicobacter aliphatic amidase AmiE polypeptides, and DNA sequences encoding those polypeptides |
US6585975B1 (en) * | 1998-04-30 | 2003-07-01 | Acambis, Inc. | Use of Salmonella vectors for vaccination against helicobacter infection |
AU770498B2 (en) * | 1998-06-19 | 2004-02-26 | Merieux Oravax | LT and CT in parenteral immunization methods against helicobacter infection |
WO2000003730A1 (en) * | 1998-07-16 | 2000-01-27 | Cheil Jedang Corporation | Urease based vaccine against helicobacter infection |
EP1278768B1 (en) * | 2000-04-27 | 2006-11-15 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Method for identifying helicobacter antigens |
CA2821422C (en) * | 2010-12-22 | 2024-01-02 | Intervet International B.V. | Vaccines comprising live aro mutant bordetella bronchiseptica |
WO2012139137A2 (en) | 2011-04-08 | 2012-10-11 | Tufts Medical Center, Inc. | Pepducin design and use |
CA3005029A1 (en) | 2015-11-13 | 2017-05-18 | Oasis Pharmaceuticals, LLC | Protease-activated receptor-2 modulators |
CN112048008B (zh) * | 2020-08-12 | 2021-06-15 | 河北医科大学第四医院(河北省肿瘤医院) | 一种幽门螺杆菌b细胞耐受表位及其制备的抗体 |
CN112143741B (zh) * | 2020-09-07 | 2022-09-20 | 中国科学院南海海洋研究所 | 一种生物膜基因岛GIVal43097及其切除方法 |
CN112190704B (zh) * | 2020-10-13 | 2022-11-15 | 宁夏医科大学 | M细胞靶向性重组乳酸菌疫苗及制备方法与应用 |
CN112143750B (zh) * | 2020-10-13 | 2022-12-27 | 宁夏医科大学 | 靶向m细胞的重组乳酸菌表面展示系统、重组乳酸菌疫苗及制备方法与应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5695983A (en) * | 1990-12-18 | 1997-12-09 | The General Hospital Corporation | Salmonella vaccines |
DE4041045A1 (de) * | 1990-12-20 | 1992-07-02 | Max Planck Gesellschaft | Zweiphasen-systeme fuer die produktion und praesentation von fremdantigen in hybriden lebendimpfstoffen |
FR2682122B1 (fr) * | 1991-10-03 | 1995-06-09 | Pasteur Institut | Nouveaux genes d'helicobacter pylori. leur utilisation pour la preparation de souches recombinantes de h. pylori. |
US5348867A (en) * | 1991-11-15 | 1994-09-20 | George Georgiou | Expression of proteins on bacterial surface |
WO1995014093A1 (en) * | 1993-05-19 | 1995-05-26 | Institut Pasteur | Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
EP0654273A1 (en) * | 1993-11-18 | 1995-05-24 | Harry H. Leveen | Pharmaceutical product and method for treatment |
WO1996026740A1 (en) * | 1995-02-27 | 1996-09-06 | Enteron Limited Partnership | Methods and compositions for production of customized vaccines for diseases associated with antigens of microorganisms |
HUP9801266A3 (en) * | 1995-04-28 | 1999-07-28 | Oravax Inc Cambridge | Multimeric, recombinant urease vaccine |
-
1996
- 1996-10-11 EP EP96116337A patent/EP0835928A1/en not_active Withdrawn
-
1997
- 1997-09-01 AT AT97940148T patent/ATE392429T1/de not_active IP Right Cessation
- 1997-09-01 PL PL97332575A patent/PL332575A1/xx not_active IP Right Cessation
- 1997-09-01 EP EP97940148A patent/EP0931093B1/en not_active Expired - Lifetime
- 1997-09-01 AU AU42084/97A patent/AU734635B2/en not_active Ceased
- 1997-09-01 DE DE69738641T patent/DE69738641D1/de not_active Expired - Lifetime
- 1997-09-01 CA CA002268033A patent/CA2268033A1/en not_active Abandoned
- 1997-09-01 WO PCT/EP1997/004744 patent/WO1998016552A1/en active IP Right Grant
- 1997-09-01 CN CNB971995516A patent/CN1215167C/zh not_active Expired - Fee Related
- 1997-09-01 JP JP51794498A patent/JP2001510986A/ja not_active Ceased
- 1997-09-01 TR TR1999/01450T patent/TR199901450T2/tr unknown
- 1997-09-01 BR BR9713254-3A patent/BR9713254A/pt not_active Application Discontinuation
- 1997-09-01 KR KR10-1999-7003168A patent/KR100510928B1/ko not_active IP Right Cessation
- 1997-09-01 NZ NZ335050A patent/NZ335050A/xx unknown
- 1997-09-01 IL IL12936697A patent/IL129366A0/xx unknown
-
1999
- 1999-04-09 NO NO991692A patent/NO991692L/no unknown
Also Published As
Publication number | Publication date |
---|---|
KR100510928B1 (ko) | 2005-08-31 |
NO991692L (no) | 1999-06-04 |
KR20000049090A (ko) | 2000-07-25 |
EP0931093B1 (en) | 2008-04-16 |
EP0835928A1 (en) | 1998-04-15 |
JP2001510986A (ja) | 2001-08-07 |
EP0931093A1 (en) | 1999-07-28 |
IL129366A0 (en) | 2000-02-17 |
ATE392429T1 (de) | 2008-05-15 |
AU734635B2 (en) | 2001-06-21 |
PL332575A1 (en) | 1999-09-27 |
BR9713254A (pt) | 1999-11-03 |
DE69738641D1 (de) | 2008-05-29 |
CN1215167C (zh) | 2005-08-17 |
NO991692D0 (no) | 1999-04-09 |
AU4208497A (en) | 1998-05-11 |
CA2268033A1 (en) | 1998-04-23 |
CN1246867A (zh) | 2000-03-08 |
NZ335050A (en) | 2000-08-25 |
WO1998016552A1 (en) | 1998-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199901450T2 (tr) | Helicobacter pylori canli asisi. | |
DE69327534D1 (de) | Impfstoffe gegen diphtherietoxin | |
NO880354L (no) | Stoetsikker anordning for beskyttelse av styreenheter, spesielt fjernstyreenheter for tv. | |
DE68917157T2 (de) | Einrichtung zur übertragung von energie. | |
DE69426051D1 (de) | Infektiösen Bronchitis Virus 4/91 enthaltender Geflügel-Impfstoff | |
DK0707062T3 (da) | Maltosephosphorylase, trehalosephosphorylase, plesiomonas stamme og fremgangsmåde til fremstilling af trehalose | |
NO910362D0 (no) | Siloxancopolymerer som oppviser alkenylgrupper, fremgangsmaate for fremstilling av disse og anvendelse av disse. | |
DE69738512D1 (de) | Epstein-barr virus type b ctl epitopen | |
DK0975360T3 (da) | Bovint respiratorisk og enterisk coronavirus som vaccine | |
DK282384D0 (da) | Malariaassocieret antigen, fremgangsmaade til fremstilling deraf og vaccine indeholdende antigenet | |
PT744027E (pt) | Utilizacao de metodos para identificar oligopeptidos de sinal hidrofilicos | |
GB9818133D0 (en) | Vaccine | |
IT8422159A0 (it) | 16-fluoro-16,17-dideidro prostanoidi e procedimento per laloro preparazione. | |
BR9706813B1 (pt) | bactéria transgênica, processo para a preparação de um polipeptìdeo e vacina. | |
EP0621790A4 (en) | Attenuated, live vaccine for delaware strain ibdv. | |
IL88622A0 (en) | Dna sequences which code for an antigenic protein,antigens coded for by said dna sequences and a vaccine and method for protecting birds using the same | |
DE69615537D1 (en) | Helicobacter pylori antigen | |
NL300165I2 (nl) | Babesiavaccin. | |
NZ316110A (en) | vaccine containing an antigen from H. Influenzae and an antigen from influenza virus | |
MX9708226A (es) | Vacunas que contienen una saponina y un esterol. | |
ATE100859T1 (de) | Durch virusneutralisierende und schuetzende monokonale antikoerper erkanntes ibdv vp2 epitop. | |
NO941389L (no) | Skjæreinnretning, f.eks. for skjæring av fjell | |
DK231590D0 (da) | Klemme til sammenholdning af hjoerner mellem vaegdele af traadnetmateriale, f.eks. minkbure |